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Abstract 
Background: Ghana has developed two main community‑based strategies that aim to increase access to quality 
treatment for malaria, diarrhoea and pneumonia: the Home‑based Care (HBC) and the Community‑based Health 
Planning and Services (CHPS). The objective was to assess the effectiveness of HBC and CHPS on utilization, appropri‑
ate treatment given and users’ satisfaction for the treatment of malaria, diarrhoea and pneumonia.
Methods: A household survey was conducted 2 and 8 years after implementation of HBC in the Volta and Northern 
Regions of Ghana, respectively. The study population was carers of children under‑five who had fever, diarrhoea and/
or cough in the last 2 weeks prior to the interview. HBC and CHPS utilization were assessed based on treatment‑seek‑
ing behaviour when the child was sick. Appropriate treatment was based on adherence to national guidelines and 
satisfaction was based on the perceptions of the carers after the treatment‑seeking visit.
Results: HBC utilization was 17.3 and 1.0 % in the Volta and Northern Regions respectively, while CHPS utilization 
in the same regions was 11.8 and 31.3 %, with large variation among districts. Regarding appropriate treatment of 
uncomplicated malaria, 36.7 % (n = 17) and 19.4 % (n = 1) of malaria cases were treated with ACT under the HBC in 
the Volta and Northern Regions respectively, and 14.7 % (n = 7) and 7.4 % (n = 26) under the CHPS in the Volta and 
Northern Regions. Regarding diarrhoea, 7.6 % (n = 4) of the children diagnosed with diarrhoea received oral rehydra‑
tion salts (ORS) or were referred under the HBC in the Volta Region and 22.1 % (n = 6) and 5.6 % (n = 8) under the 
CHPS in the Volta and Northern Regions. Regarding suspected pneumonia, CHPS in the Northern Region gave the 
most appropriate treatment with 33.0 % (n = 4) of suspected cases receiving amoxicillin. Users of CHPS in the Volta 
Region were the most satisfied (97.7 % were satisfied or very satisfied) when compared with those of the HBC and of 
the Northern Region.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Malaria Journal
*Correspondence:  blanca.escribano@lshtm.ac.uk 
1 Disease Control Department, London School of Hygiene and Tropical 
Medicine, London, UK
Full list of author information is available at the end of the article
Page 2 of 15Ferrer et al. Malar J  (2016) 15:340 
Background
During the past 30  years, the under-five mortality rate 
has declined in Ghana from 145/1000 live births in 1998 
to 60/1000 live births in 2014 with an infant mortality 
rate of 41/1000 and a neonatal mortality rate of 29/1000 
live births. These mortalities are higher in the north of 
the country and in the rural areas. Despite this decline in 
under-five  year mortality, the Millennium Development 
target of 40/1000 was not reached [1]. The main causes 
of under-five mortality are neonatal related causes (38 %), 
malaria (20 %), pneumonia (11 %) and diarrhoea (8 %) [2]. 
In 2012, the Child Survival Call to Action set “A Promise 
Renewed” with the target of decreasing under-five mor-
tality rates to 20 or fewer deaths per 1000 live births by 
2035 in all countries [2].
Access to anti-malarials within 24  h of the onset of 
malaria symptoms is vital to prevent progression to 
severe malaria or death. The Roll Back Malaria partner-
ship recommends that 100  % of those suffering from 
malaria should have prompt access to affordable and 
appropriate treatment within 24 h of onset of symptoms 
[3, 4].
There are three key strategies that seek to improve 
physical access to quality treatment which are: extension 
and quality improvement of formal health care systems, 
improvement in the informal private sector (mainly drug 
shops), and the home-based care (HBC) of fevers [5]. The 
World Health Organization and the Roll Back Malaria 
partnership states that in settings with limited access to 
health facilities, diagnosis and treatment should be pro-
vided at community level through community case man-
agement of malaria, recommending the introduction 
of rapid diagnostic test (RDT) and rectal artesunate for 
referral, when possible [4, 6, 7]. Malaria HBC has been 
shown to be effective and cost effective especially in 
areas with high malaria transmission, and in areas with 
medium transmission and low coverage of health facili-
ties [8–13]. Integrated HBC or integrated community 
case management (iCCM) does not reduce the quality of 
malaria case management if adequate training is provided 
and supervision is maintained [14]. Issues related to 
implementation (e.g., availability of CBAs, availability of 
drugs or access to facilities), may decrease the expected 
impact of the strategy. The United Nations Children’s 
Fund (UNICEF) and the World Health Organization offi-
cially endorsed iCCM in 2012 [15].
Ghana has developed two main community-based 
interventions or delivery strategies that aim to reduce 
barriers to physical access to quality treatment: the HBC 
and the community-based health planning and services 
(CHPS).
The HBC strategy started on a pilot basis in Ghana 
in 1999 to treat suspected malaria cases [16]. The pilot 
programme initially used chloroquine, shifting to arte-
misinin-based combination therapy (ACT) in 2005 [17]. 
In 2009 and in the context of integrated management of 
childhood illness (IMCI), Ghana developed the Home 
Management of Malaria, ARI and Diarrhoea in Ghana 
[16] also called iCCM. HBC (or iCCM) was defined as 
prevention, early case detection and prompt and appro-
priate treatment of fevers, ARI and diarrhoea in the 
community.
The HBC strategy corresponds to the lowest level of 
health care delivery in Ghana and it is designed to be 
implemented within the health system, with commu-
nity-based agents (CBA) reporting their activities to 
care providers at the CHPS compounds (when existing) 
or to the next health facility level. All CBAs in the three 
northern regions (Northern, Upper East and Upper 
West Regions) provide treatment for malaria, diarrhoea 
and suspected pneumonia cases based on clinical symp-
toms and with the support of ARI timers for measur-
ing the respiratory rate to diagnose pneumonia cases, 
mainly with the financial support of UNICEF. Those in 
the rest of the country have received the same training 
as the three northern regions but provide only malaria 
treatment with the support of the Global Fund to fight 
AIDS, TB and malaria (GFATM), and are supposed to 
refer diarrhoea and suspected pneumonia cases for fur-
ther management. Other projects implemented by non-
governmental organizations support integrated HBC on 
a smaller scale in different regions of the country. The 
HBC guidelines state that the service provided should 
be free, although some regions (such as the Northern 
Region) decided that users should give a small amount 
of money to CBAs to avoid risking lack of continu-
ity and commitment of the strategy as experienced in 
other countries [8, 18, 19]. No target was set for iCCM 
Conclusions: HBC showed greater utilization by children under‑five years of age in the Volta Region while CHPS was 
more utilized in the Northern Region. Utilization of HBC contributed to prompt treatment of fever in the Volta Region. 
Appropriate treatment for the three diseases was low in the HBC and CHPS, in both regions. Users were generally 
satisfied with the CHPS and HBC services.
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utilization as a proportion of other delivery points for 
treatment of sick children.
The CHPS strategy started in 1999 after a pilot phase 
conducted in 1994 [20] attempting to respond to the 1978 
Alma Ata Conference and the ‘Health for All’ principle. A 
key component of the CHPS strategy is that traditional 
leaders of the community must accept the CHPS con-
cept and commit themselves to supporting it. The CHPS 
strategy is based upon a basic facility known as a commu-
nity health compound, where health care is provided by 
a resident community health nurse or community health 
officer who also does a 90  days cycle visiting the com-
munities she/he serves at least once within that period. 
The services provided include immunizations, family 
planning, supervising delivery (if trained staff available), 
antenatal/postnatal care, treatment of common diseases 
such as malaria, diarrhoea and acute respiratory infec-
tions (ARI) and health education. These services are free 
for those having a valid national health insurance card. 
No target was set for CHPS utilization as a proportion of 
other delivery points for treatment of sick children. The 
target for CHPS coverage is that a geographical area of a 
4 km radius and between 4500 and 5000 persons should 
be covered by a CHPS [21, 22].
After several years of national implementation, there 
is the need to know how effective HBC and CHPS are 
at delivering care for children with fever, diarrhoea or 
cough. There are several studies that looked at the HBC 
in Ghana. However, most of these studies focused in few 
districts, looked particularly at malaria HBC and were 
conducted in a more “controlled” context [23–27]. This 
study aims to assess the effectiveness of the national 
implementation of HBC and CHPS in terms of utiliza-
tion of services, appropriate treatment given and users’ 
satisfaction in the current context, without additional 
supervision, in a larger area and considering the manage-
ment of fever, diarrhoea and cough for children under-
five years old.
Methods
Ethics
Ethical approval was obtained from the Ghana Health 
Service-Ethical review committee (ID NO; GHS-ERC: 
04/09/13) and from the Ethics Committee of LSHTM 
(ethics ref: 6442). Administrative approval was obtained 
from the respective regions and districts. Carers of chil-
dren gave written consent to be interviewed.
Study site
The Volta and Northern Regions were purposively 
selected. The principal researcher wanted to include a 
region implementing iCCM and one malaria only HBC, 
to have a better picture of HBC in Ghana. Based on this 
first requirement, the National Malaria Control Pro-
gramme (NMCP) suggested the Volta and Northern 
Regions. The Volta Region targeted only rural districts 
for the HBC implementation and implements mostly 
malaria HBC (with the exception of some communities 
supported by NGOs which implement integrated HBC), 
despite all districts received drugs for the management of 
diarrhoea and suspected pneumonia in 2013. The North-
ern Region implements iCCM due to availability of funds 
from UNICEF. Based on the monthly activities reported 
through the routine monitoring information (District 
Health Information System-DHIMS II), the NMCP had 
some concerns on the low performance of iCCM in 
Northern Region compared to the other two northern 
regions (Upper East and Upper West Regions), although 
the iCCM coordinator in the Northern Region believed 
this low performance was due to under reporting of 
activities. In contrast, the NMCP was satisfied with the 
malaria HBC implementation in the Volta Region. Select-
ing one “good” and “bad” performing region was believed 
to be a good strategy to contrast results with those of 
DIMS II and to see possible differences that could help 
identify enablers and barriers of the HBC implemen-
tation in Ghana. The CHPS strategy is uniform across 
regions of the country.
The Volta Region has a malaria prevalence of 17  %, 
diarrhoea prevalence of 7.6 % and suspected pneumonia 
prevalence of 2.1 % in children under-five (MICS 2011). 
The rural population corresponds to 66  % of the total 
population. Two rainfall patterns occur in the southern 
area of the Volta Region, one major season is in April/
July with a peak in June and one minor season is in Sep-
tember/November with a peak in October. The north of 
Volta Region has one rainy season—May to October with 
a peak in August.
The Northern Region has a malaria prevalence of 48 %, 
diarrhoea prevalence of 21.4 % and suspected pneumonia 
prevalence of 6.3  % in children under-five (MICS 2011) 
[28]. The rural population corresponds to 70  % of the 
total population. In the north the rainy season begins in 
May and ends in October [29]. Climatically, religiously, 
linguistically, and culturally, the Northern Region differs 
greatly from the politically and economically dominat-
ing regions of southern Ghana, and it is similar to the 
two other regions in the north of Ghana (Upper East and 
Upper West).
Study design and sampling procedures
This was an observational study post intervention with-
out controls using a cross sectional household survey. 
The effectiveness of the implementation of appropriate 
treatment was assessed against national guidelines. The 
study population were carers of children under-five years 
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of age, who had fever, cough and or diarrhoea in the last 
2 weeks prior to the interview.
The sample size was estimated using the standard for-
mula for estimation of a proportion and adjusting for 
clustering: [3.84p(1 − p)/e2] × DE [30]. A prevalence of 
50  % of the population who are satisfied with the strat-
egies was used to obtain a conservative sample size and 
ensure sufficiency for the estimation of utilization of 
the community services and several outcomes. A design 
effect of 1.5 [31] and a precision of 5 % were used. Adding 
10 % for non-response, the sample size required in each 
region was 633, giving a total sample size of 1267 house-
holds with a child with fever, diarrhoea or cough in the 
2 weeks preceding the survey.
A stratified three-stage cluster survey was conducted 
in each region. In order to have the sample representa-
tive of the whole region, whilst being logistically feasible, 
regions were divided into three areas. From each area, 
two districts and from each district, four clusters were 
selected using probability proportional to size. Then, 
from each cluster, 27 households were selected, making 
a total of 648 in each region. To select the districts (first 
stage) the list of districts implementing HBC (all dis-
tricts implement the CHPS strategy) with its population 
was used. To select the clusters (second stage) the list of 
communities implementing HBC with its population was 
used. Households with children under-five that had fever, 
diarrhea or cough in the last 2 weeks prior to the inter-
view were randomly selected in each cluster using a mod-
ified expanded programme on immunization sampling 
technique (third stage) [32]. To select households, a loca-
tion near the centre of the community was first identified 
and a random direction was defined by spinning a pen. 
A random household along the chosen direction point-
ing outwards from the centre of the community to its 
boundary was chosen and checked for compliance with 
the inclusion and exclusion criteria. Whether the criteria 
were met or not, the next closest household was visited 
until the required number of households with a child 
with a fever, diarrhoea or cough in the 2 weeks preced-
ing the survey were surveyed. Interviews were conducted 
with the carer of the sick child. In cases where there was 
more than one eligible child in a household, only one was 
selected randomly by ballot paper.
Data collection
Data collection was done during the 5th to 16th April 
2014 in the Volta Region and during the 23rd June to 3rd 
July 2014 in the Northern Region. Three teams of four 
field workers with one field supervisor were recruited 
in Dodowa township for the Volta Region data collec-
tion and in Tamale township for the Northern Region 
data collection. The recruitment followed a standard 
procedure which included an interview, previous expe-
rience as a field worker in DHRC and secondary educa-
tion level. The training was done in Dodowa for the Volta 
Region team and in Tamale for the Northern Region 
team. The training was for a week and included 1-day 
pilot testing of the questionnaire. The same field supervi-
sors and the trainers were used in both regions.
Data collection was done using a structured question-
naire, which included socio-demographic information of 
the care taker, care-seeking behaviour, experience with 
CBAs and other health providers, knowledge of the three 
diseases and household characteristics.
Definitions
Appropriate provider refers to public or private medi-
cal facility, CHPS, CBAs or licensed chemical shop [28]. 
HBC is delivered by CBAs. Utilization of HBC or CHPS 
is defined as carers taking their child under-five to a CBA 
or a CHPS, respectively, when the child has symptoms of 
fever, cough or diarrhoea.
Flexibility of time of a CBA or of a health facility 
to attend a child refers to “open hours”, meaning the 
moments during the day that a child can be seen by a 
provider.
User satisfaction refers to carers experience with the 
service received after the treatment-seeking visit. Defini-
tions specific to case management of malaria, pneumonia 
and diarrhoea, and their differentials by HBC and CHPS 
used in the study are presented in Table 1.
Data management and analysis
Data were double entered and validated using EpiData 
3.1. Survey data processing and analysis was done using 
STATA 12. Initial data examination and prevalence esti-
mates were obtained using tabulations adjusted for sur-
vey design. Pearson’s design based Chi square was used 
to test for associations. Survey logistic regression was 
used to obtain adjusted estimates.
To explore the potential association between key out-
come variables and potential predictors, the crude OR 
was obtained using univariate logistic regression, and 
the adjusted OR using multivariate analysis based on 
the framework below (Table 2; Fig. 1). The association of 
each factor (adjusted only for district) with the outcome 
was estimated. All individual factors whose association 
reached significance at p  <  0.1 were included in a mul-
tivariate analysis. All factors that remained significantly 
associated with the outcome (p < 0.1) in this model were 
retained. The variables included in this model were the 
core group of individual variables. The same procedure 
was followed for community and health system factors. 
All remaining individual, community and health system 
variables were then combined in a multivariate analysis. 
Page 5 of 15Ferrer et al. Malar J  (2016) 15:340 
All variables that remained significantly associated with 
the outcome (p < 0.05) in this model were retained in the 
final model. Two-way interactions were tested with all 
the variables retained in the final model.
Principal components analysis was used to cre-
ate socio-economic quintiles and compare outcomes 
across these quintiles. The variables used to generate 
the socioeconomic quintiles were ownership of the 
house, number of rooms, type of flooring, availability 
of electricity, radio, television, refrigerator, telephone, 
bicycle, motorcycle, car, canoe, tractor, source of water, 
type of sanitation, main source for cooking and num-
ber of people living in the household. The advantage of 
using a principal components analysis over the more 
traditional methods based on income and consumption 
expenditure is that it avoids many of the measurement 
problems like recall bias, seasonality and data collec-
tion time [33].
Results
A total of 1356 interviews were conducted in the Volta 
and Northern Regions (685 and 671 respectively) 
(Table 3). Among the children included in the study, fever 
was the most prevalent reported symptom during the 
last 2  weeks [621/671 (90.9  %) in the Volta Region and 
635/685 (94.4  %) in the Northern Region], followed by 
cough [408/671 (65.9 %) in the Volta Region and 334/685 
(53.1 %) in the Northern Region] and diarrhoea [287/671 
(49 %) in the Volta and 291/685 (42.7 %) in the Northern 
Region] (Table 4).
Table 1 Study definitions
a ARI timers are available in the Northern Region under the iCCM strategy to help diagnose suspected pneumonia. If severe pneumonia is suspected, the child must 
be referred to a CHPS compound or a Health Centre
b Nurses at CHPS compounds do not have ARI timers. The diagnosis is made based on clinical signs. If a severe pneumonia case is suspected, the children must be 
referred to a higher level of health facility. Some district hospitals, all regional hospitals and teaching hospitals have X-Rays to help diagnose pneumonia. Health 
centres, district hospitals, regional hospitals and teaching hospitals have laboratory facilities to help diagnose malaria, diarrhoea and pneumonia
Definitions HBC [16] CHPS [53]
Malaria All fever cases when no laboratory tests are 
available
All fever cases when no laboratory tests are available or when malaria test 
was positive
General danger signs Vomiting, convulsions, unconscious or not 
breastfeeding
Vomiting, convulsions, unconscious or not breastfeeding
Severe malaria signs Little or no urine, dark coloured urine, marked 
jaundice or abnormal bleeding
Little or no urine, dark coloured urine, marked jaundice or abnormal 
bleeding
Appropriate treatment 
of malaria
Children aged 6 months to 5 years diagnosed 
with malaria receiving 3 days of ACT
If more than 7 days with fever, general danger 
signs or severe malaria signs, child must be 
referred with rectal artesunate
Children aged 2 months to 5 years diagnosed with malaria receiving 
3 days of ACT
If more than 7 days with fever, general danger signs or severe malaria 
signs, child must be referred with IM quinine, IM or EV or rectal artesu‑
nate plus an IM dose of chloramphenicol
Prompt treatment of 
malaria
Malaria cases that received an antimalarial 
drug in within the first 24 h of the onset of 
symptoms
Malaria cases that received an antimalarial drug in within the first 24 h of 
the onset of symptoms
Diarrhoea Three or more loose or watery stools in a 24‑h 
period
Three or more loose or watery stools in a 24‑h period
Appropriate treatment 
of diarrhoea
Children older than 6 months with diarrhoea of 
less than 7 days that receive ORS and zinc for 
14 days
If the child is less than 6 months, had diarrhoea 
for 7 days or more, blood in stools or is dehy‑
drated, he/she should be referred with ORS
Children with diarrhoea of less than 14 days receiving ORS and zinc for 
14 days
If diarrhoea for 14 days or more, blood in stools or is severely dehydrated, 
he/she should be referred to hospital with ORS
ARI or suspected pneu‑
monia
Cough with fast or difficult breathinga Cough with fast or difficult breathingb
Severe pneumonia Noisy breathing or chest in‑drawing Noisy breathing or chest in‑drawing
Appropriate treatment 
for suspected pneu‑
monia
Children older than 6 months with cough and 
fast or difficult breathing of less than 7 days 
receiving amoxicillin for 5 days
If the child is less than 6 months or had symp‑
toms for 7 days or more, he/she should be 
referred
If there are signs of severe pneumonia, he/she 
should be referred with amoxicillin
Children older than 2 months with cough and fast or difficult breathing of 
less than 14 days receiving amoxicillin or cotrimoxazole for 5 days
If the child is less than 2 month or had symptoms for 14 days or more, he/
she should be referred
If there are signs of severe pneumonia, he/she should be referred with IM 
chloramphenicol
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Utilization of HBC and CHPS strategies
Almost all respondents in both regions (93 %) indicated 
that they sought some form of care when the child’s 
symptoms started in the past 2  weeks preceding the 
survey, and more than 86  % did it from an appropriate 
provider (Table  4). Seeking care from an appropriate 
provider was not associated with the SES (p =  0.6 and 
p  =  0.2 in the Volta and Northern Regions) but it was 
associated with having an active NHIS card in the North-
ern Region (p = 0.01).
About 30 % of carers visited a community-based health 
provider (HBC or CHPS) when their child had fever, 
cough or diarrhoea (29.1 and 32.3  % in the Volta and 
Northern Region). Although CHPS coverage was found 
to be similar in both regions (41 and 43 % of households 
have a CHPS as the closest health facility in the Volta 
and Northern Region) and the distance to the closest 
health facility is larger in the Northern Region (61 versus 
45 % have a health facility at less than 1 h walking in the 
Volta and the Northern Region), HBC was more utilized 
than CHPS in the Volta Region (17.3 % of carers visited 
a CBA) and CHPS were much more used than HBC in 
the Northern Region (31.1  % of carers visited a CHPS) 
(Table 4).
Within regions the utilization of HBC and CHPS varied 
by districts (Table 5). HBC utilization in the Volta Region 
ranged from 35.3 % (95 % confidence interval (CI) 20.8–
53) in Krachi East to 0.3 % (95 % CI 0.01, 0.9) in Jasikan 
(p = 0.001). In the Northern Region HBC utilization was 
generally very low and the percentage of carers report-
ing that they were not aware of CBAs or that they do 
not have CBAs in the community was higher than in the 
Volta Region [314/685 (40.6 %) versus 213/671 (29.8 %), 
respectively]. The utilization of CHPS in the Volta Region 
varied from 27.1 % (95 % CI 2.5, 84.3) in Krachi West to 
2.5 % (95 % CI 0.3, 15.2) in Hohoe municipal (p = 0.2). 
In the Northern Region, the utilization of CHPS ranged 
from 56.5 (27.9, 81.2) in Saboba to 4.7 (2.4, 9.2) in Central 
Gonja (p = 0.004).
Only 282/671 (38.1  %) of carers in the Volta Region 
and 397/685 (59.1  %) in the Northern Region reported 
that they sought care for their child from an appropri-
ate provider the same day or the day after the onset of 
fever, diarrhoea or cough (Table 4). While children seek-
ing care from a CBA within 24 h of onset of symptoms 
was significantly higher when compared with all other 
appropriate providers collated in the Volta Region [58/90, 
56 % (95 % CI 48.7, 63.08) versus 224/519, 39.4 % (95 % 
CI 29.2, 50.5), p  =  0.03], children seeking care from 
CHPS in the Northern Region also tended to do it more 
promptly when compared with other appropriate provid-
ers collated [163/227, 77.0 % (95 % CI 70.2, 82.7) versus 
234/357, 63.6 % (95 % CI 50.2, 75.2), p = 0.02].
Factors associated with HBC and CHPS utilization in the 
Volta Region
The final regression model showed that carers of sick 
children were more likely to visit a CBA if children were 
older than 6 months (adjusted OR 6–23 months 4.1, 95 % 
CI 3, 5.5; adjusted OR ≥24 months 4.1, 95 % CI 1.4, 11; 
Table 2 Variables of the framework for HBC and CHPS uti-
lization
Category Variable
Individual factors Age of child
Sex of child
Age of care taker
Education of care taker
Household socio economic status
Community factors Preventive messages sent by CBAs and CHPS
Preventive messages sent by other sources
Open hours (flexibility of time) of a CBA and 
CHPS to attend a child
Health system factors Active NHIS card
Distance to a health facility
Type of closest facility
Open hours (flexibility of time) of the closest 
facility
Individual factors
Community factors
Health system factors
Fig. 1 Simplified conceptual hierarchical framework for HBC and 
CHPS utilization
Table 3 Number of  interviews conducted by  district and   
region
Volta region Northern region
District name Freq. District name Freq.
Hohoe municipality 115 Central Gonja 114
Jasikan 113 East Gonja 118
Ketu North 98 East Mamprusi 120
Krachi East 114 Saboba 110
Krachi West 121 Sawla‑Tuna‑Kalba 106
North Tongu 110 Tolon Kumbungu 117
Total interviews 671 Total interviews 685
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p =  0.01), or if they lived further than 15  min walking 
distance to a health facility (adjusted OR health facil-
ity 15–30 min walking 36.9, 95 % CI 1.6, 805), p = 0.03; 
30 min–1 h adjusted OR 61.8, 95 % CI 4.8, 788, p = 0.01; 
1–2 h adjusted OR 85, 95 % CI 6.8, 1056, p = 0.01; ≥2 h 
adjusted OR 36.4 (1.5, 851), p = 0.03) (Additional file 1). 
Flexibility of time of the CBA to attend to a child had a 
borderline association with utilization of HBC: adjusted 
OR 14 (95 % CI 0.4, 417), p = 0.08. Carers from house-
holds in higher socio-economic quintiles were less likely 
to take their children to a CBA than those in the lowest 
socio-economic quintile (adjusted OR lower middle quin-
tile 0.2, 95  % CI 0.08, 0.7, p =  0.03; adjusted OR upper 
middle quintile 0.3, 95 % CI 0.06, 1.4, p = 0.09; adjusted 
OR upper quintile 0.3, 95  % CI 0.01, 1.5, p =  0.08). No 
association with the middle SES quintile compared with 
the lower level was found.
No interaction was found between HBC utilization and 
any other variable. No factor was found to be associated 
with the utilization of CHPS compounds.
Table 4 Prevalence of symptoms and care seeking behaviour by region
a Fever refers to hot body or chills
b Weighted estimates
Indicator Volta region Northern region N %b
N %b
Had fever during past 2 weeksa 621/671 90.9 635/685 94.4
Had diarrhoea during past 2 weeks 287/671 49.0 291/685 42.7
Had cough during past 2 weeks 408/671 65.9 334/685 53.1
Had suspected pneumonia during past 2 weeks 153/671 21.4 80/685 10.2
Sought care (for any of the three symptoms) 639/671 93.1 626/685 92.8
From CBA 90/671 17.3 8/685 1.0
From CHPS 61/671 11.8 228/685 31.3
From health centre 130/671 12.2 155/685 21.1
From hospital 153/671 24.2 83/685 13.0
From private clinic 19/671 4.0 25/685 7.3
From licensed chemical seller 153/671 19.5 88/685 14.9
From drug peddler 29/671 3.3 33/685 5.5
From traditional healer 0/671 0 6/685 0.6
From other providers 4/671 0.4 0/685 0
Care not sought 32/671 6.8 59/685 7.3
Not aware/don’t have CBA 213/671 29.8 314/685 40.6
Sought care in the first 24 h (for any of the three symptoms) 299/671 40.0 413/685 62.5
From CBA 58/90 56.0 6/8 79.9
From CHPS 22/61 36.3 163/228 76.9
From health centre 62/130 33.8 104/155 72.4
From hospital 60/153 45.7 54/83 59.0
From private clinic 4/19 20.6 12/25 47.8
From licensed chemical seller 74/153 40.8 58/88 59.1
From drug peddler 16/29 49.7 14/33 55.6
From traditional healer 0 0 2/6 43.2
From other providers 3/4 54.7 0 0
Sought care in the first 24 h in case of fever 278/621 40.2 385/635 62.5
Sought care in the first 24 h in case of diarrhoea 140/287 40.6 159/291 58.3
Sought care in the first 24 h in case of cough 178/408 39.4 188/334 54.9
Sought care in the first 24 h in case of suspected pneumonia 71/153 33.4 47/80 56.4
Sought care from appropriate provider (for any of the three symptoms) 609/671 89.6 587/685 86.4
Sought care from appropriate provider in first 24 h (for any of the three symptoms) 282/671 38.1 397/685 59.1
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Factors associated with HBC and CHPS utilization in the 
Northern Region
Due to low HBC utilization in the Northern Region 
(n =  8) it was not possible to look for predictors. With 
regards to CHPS utilization, carers having as the closest 
facility a health centre or a private clinic were less likely 
to go to a CHPS compound (adjusted OR health cen-
tre 0.01, 95 % CI 0.002, 0.08; adjusted OR private clinic 
0.008, 95 % CI 0.001, 0.5, p = 0.02 (Additional file 2). No 
interaction was found.
Appropriate treatment of malaria under the HBC and CHPS 
strategies
Regarding appropriate treatment of malaria, 19/77 
(45.3 %) and 1/7 (14.9 %) of the children with fever that 
were taken to a CBA received ACT or were referred with 
artesunate to a health facility in the Volta and Northern 
Regions, respectively (Additional file  3); 18/77 (45.0  %) 
and 1/7 (14.9  %) in the Volta and Northern Regions 
received ACT and 12/77 (14.9 %) and 1/7 (14.9 %) in the 
Volta and Northern Regions received ACT within 24  h 
of the onset of symptoms. In Volta Region, some carers 
reported that they were prescribed amodiaquine mono-
therapy (6/78) and quinine (2/77) from CBAs. CBAs are 
not licensed to prescribe amodiaquine or quinine and 
amodiaquine should not be given as a monotherapy. 
However it is difficult to determine if carers were actually 
given amodiaquine in monotherapy or if carers reported 
“amodiaquine” as a short name of “artesunate-amodi-
aquine”. How these two drugs were supplied to CBAs was 
not clear: they may have been provided from the health 
facilities or CBAs may have purchased them at a local 
pharmacy for selling. However, carers did not report that 
they paid for these drugs.
In the case of the CHPS, 34/55 (65.3  %) and 86/209 
(41.7 %) of the children with fever were tested for malaria 
in the Volta and Northern Regions. A high proportion of 
carers did not know the results of the test [9/37 (19.0 %) 
and 21/92 (24.9  %) in the Volta and Northern Regions 
respectively]. Of those who tested positive, 6/23 (20.8 %) 
and 14/67 (8.6  %) in the Volta and Northern Regions 
were given an ACT; 0/23 (0 %) and 13/62 (35.1 %) were 
given quinine (reserved for severe malaria cases that 
should be treated in hospital [34]) and 3/23 (22.3 %) and 
2/62 (3.8 %) were given amodiaquine. When testing nega-
tive, only one case in the Volta Region was given ACT 
and none in the Northern Region. If considering together 
all uncomplicated malaria cases (those tested positive 
and fever cases without laboratory confirmation that 
were not referred), 7/40 (14.7  %) and 26/183 (7.4  %) in 
the Volta and Northern Regions received ACT (Fig. 2). If 
malaria cases treated with quinine are included, then the 
proportion of children appropriately treated increases 
especially in the Northern Region although still not sat-
isfactory: 8/40 (15.5 %) and 57/183 (35.9 %) in the Volta 
and Northern Regions. Prompt treatment with ACT or 
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Fig. 2 Case management of uncomplicated malaria under HBC and CHPS by region. (Uncomplicated malaria = cases tested positive or fevers 
when no test was conducted that were not referred). VR Volta region, NR Northern region, quin quinine, T treatment
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quinine was also low: 1/40 (2.3 %) and 43/183 (27.3 %) in 
the Volta and Northern Regions respectively.
Appropriate treatment of diarrhoea under the HBC 
and CHPS strategies
Of the children with diarrhoea that were taken to a CBA 
in the Volta Region, 4/38 (7.6 %) and 3/38 (5.7 %) received 
ORS or were referred and received ORS plus zinc or were 
referred, respectively.
In the case of the CHPS, only 6/31 (22.1  %) and 8/86 
(5.6  %) of children with diarrhoea received ORS, 7/31 
(31.3 %) and 4/86 (5.5 %) received zinc and 1/30 (0.3 %) 
and 0/86 (0 %) received ORS plus zinc in the Volta and 
Northern Regions, respectively.
Appropriate treatment of suspected pneumonia under the 
HBC and CHPS strategies
Of the children with cough with fast or difficult breathing 
that were taken to a CBA, 7/25 (31.8 %) received amoxi-
cillin or were referred in the Volta Region and 0/1 (0 %) 
received amoxicillin in the Northern Region. In the case 
of the CHPS, 1/9 (18.7 %) and 4/15 (33.0 %) in the Volta 
and in the Northern Region received amoxicillin or co-
trimoxazole according to the protocol.
Follow‑up visits, referrals and second providers’ visits
National guidelines state the CBA must conduct a fol-
low-up visit on the day after the first visit [16]. This fol-
low-up visit was conducted for 38/88 (68.8  %) and 4/8 
(32.3 %) of the cases in the Volta and Northern Regions. 
Artesunate suppositories were given along with a writ-
ten referral in 2 of the 6 fever cases referred in the Volta 
Region and in none of the two cases in the Northern 
Region. No amoxicillin was given in case of referral 
because of suspected pneumonia in either region, and 
2/8 (59.9 %) of the cough cases referred received amoxi-
cillin in the Volta Region.
After visiting a CBA, 28/90 (42.4  %) and 4/8 (63.3  %) 
of the carers in the Volta and in the Northern Region 
went to a second provider. The main reason for this sec-
ond visit in the Volta Region was children not getting 
better [24/28 (98.7 %)] while in the Northern Region the 
reported reasons were not getting better [2/4 (25.5  %)] 
and to get drugs [2/4 (74.5 %)] (Additional file 4). After 
visiting a CHPS, 14/61 (28.0 %) and 21/228 (7.9 %) in the 
Volta and in the Northern Region went to a second pro-
vider. The facilities more often visited were the licensed 
chemical sellers in the Volta Region to buy drugs [8/14 
(50.4  %)] and health centres in the Northern Region 
because the child was not getting better [9/21 (23.8 %)].
Users’ reported satisfaction
In general, users of HBC and CHPS in both regions 
reported that they were satisfied, although consistently 
more in the Volta Region (Table 6). Lack of affordability and 
availability of drugs were the factors more often reported as 
reasons for dissatisfaction with the services received.
The main reason for not being satisfied when using 
HBC in the Volta Region was unavailability of drugs [5/8 
(80.24 %)], while drugs not available, drugs not affordable 
and drugs not free [1/1, (100 %)] were the concerns in the 
Northern Region. It is important to note that three of the 
seven drugs (42 %) and 3/138 (2.1 %) given by the CBA 
in the Northern and the Volta Regions were sold to the 
carers.
Likewise, the main reason for not being satisfied when 
visiting a CHPS in the Northern Region was drugs not 
available (5/23, 39.1 %). CHPS users in the Volta Region 
reported a higher variety of reasons for not being satis-
fied (drugs not available, travel long distances, not time 
for seeking care and staff not giving information).
Discussion
This study assessed the effectiveness of HBC and CHPS 
in terms of utilization, appropriate treatment given and 
satisfaction of carers of children under-five  years of age 
with fever, diarrhoea or suspected pneumonia in the last 
2 weeks prior to the interview.
Table 6 Users’ satisfaction after visiting CBA or a CHPS by region
Very satisfied Satisfied Not sure Not satisfied Absolutely not 
satisfied
n/N % n/N % n/N % n/N % n/N %
Volta Region
 CBA 29/89 32.6 52/89 58.4 0/89 0 6/89 6.7 2/89 2.2
 CHPS 15/61 24.6 42/61 68.8 0/61 0 2/61 3.3 2/61 3.3
Northern Region
 CBA 2/8 16.1 4/8 30.1 1/8 13.6 0/8 0 1/8 39.9
 CHPS 29/228 8.4 175/228 85.2 1/228 0.1 21/228 5.3 2/228 0.8
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Utilization of HBC and CHPS
This study showed that seeking care from an appropri-
ate provider in case of fever, diarrhoea or cough was high 
in both regions and higher than that found in previous 
surveys while being coherent with the increased trend 
on seeking care because of fever: the 2011 MICS survey 
showed that approximately 44 and 43 % of fever cases in 
under-fives in the Volta and Northern Regions sought 
care from an appropriate provider at any time [28]; the 
2013 LQAS survey showed that 60  % of fever cases in 
under-fives in the Northern Region sought care at any 
time and 30 % in the first 24 h of onset of symptoms [36] 
and in the 2014 DHS 73.6 and 83.6 % of fever cases in the 
Volta and Northern Region sought care at any time [37]. 
It should be noted that data from the LQAS survey is not 
representative of the Northern Region as they purpo-
sively selected 10 districts out of 20. The MICS and the 
DHS surveys, use a similar sampling methodology but 
their sample size of children under-five presenting with 
fever was between three and 11 times smaller than this 
study.
The total utilization of community-based interventions 
was similar and slightly higher in the Northern Region 
when compared with the Volta Region (32.3 versus 
29.1  %). However utilization of HBC versus CHPS was 
different: HBC was more used in the Volta Region while 
CHPS was more used in the Northern Region.
The HBC utilization found in this study was similar 
to the 2013 LQAS survey in the Northern Region (95 % 
CI 0.7, 6.5 %). However, another study conducted in one 
district of the Ashanti and Volta Regions in 2008 [26] 
showed higher HBC utilization (more than 68 and 75 % 
respectively used HBC a year after the HBC implementa-
tion). When compared with other evaluations conducted 
in Uganda [38], which was a quasi-experimental study 
before and after 18 months implementation of HBC, and 
in Burkina Faso, which was a cross sectional study con-
ducted before and after 1 year implementation of HBC, a 
higher utilization of HBC (25 and 56 % respectively) was 
found. Two reasons could explain this higher HBC uti-
lization. Firstly, due to differences between districts: the 
study in the Ashanti and Volta Region only focussed in 
one district per region and this current study has shown 
the variation of HBC utilization among districts spe-
cially in the Volta Region). Secondly, due to differences 
between research projects and real world implementa-
tion: the length of the projects is generally shorter and 
the quality and intensity of supervision is usually better in 
research projects than in routine programme implemen-
tation. For example, the HBC strategy in the Northern 
Region was being implemented for about 8 years before 
the survey and for 2  years in the Volta Region. Longer 
time implementing the strategy might bring expertise 
but also tiredness of the CBAs and the supervisor, stock-
out of drugs and the need for CBA replenishment and 
training. The lower effectiveness of implementation of 
an intervention in the “real world” as compared to that 
found in research projects is already being discussed 
and addressed through the Implementation Research 
[39–41], which aims to bridge the implementation gap 
between knowledge and action.
Large differences in HBC utilization were observed 
between the Volta and Northern Regions. However, 
the HBC strategy in the two regions started at differ-
ent times and includes different interventions. In the 
Northern Region, HBC started in 2007 first addressing 
malaria cases, and in 2010 the management of diarrhoea 
and suspected pneumonia cases were included with the 
technical and financial support of UNICEF. The HBC in 
the Volta Region started in 2012 and includes only drugs 
for the management of malaria cases with the financial 
support of the GFATM, while diarrhoea and suspected 
pneumonia cases should be referred for further treat-
ment. Therefore, one could argue that a higher HBC uti-
lization in the Northern Region would be expected as a 
wider range of conditions are treated by the CBAs com-
pared with Volta Region (which was not the case). Con-
sidering that this study was conducted in communities 
where according to policy HBC is being implemented, it 
is surprising that 30 % of carers in the Volta Region and 
41  % in the Northern region indicated that they were 
not aware of the presence of CBAs or they did not have 
CBAs in the community. During informal communica-
tions with CBA and community chiefs while conduct-
ing the survey, the field team was informed that some 
CBAs travelled and no one had replaced them yet, others 
stopped working as they did not have drugs to work with 
and some CBAs were known in one area of the commu-
nity while not in another area, suggesting that social and 
personal issues might also affect the knowledge and the 
utilization of the CBA services. Therefore, sociocultural 
issues, stock out of CBA drugs or high turnover of CBAs 
could explain the lower utilization of HBC in the North-
ern Region as it has also been reported in other studies 
in Ghana and elsewhere as a barrier to implementation 
[27, 38]. A further qualitative study might help to under-
stand causes of the low HBC utilization in the Northern 
Region.
With respect to the Volta Region, HBC utilization was 
not associated with living far from a CHPS or with low 
flexibility of CHPS for attending patients. The HBC strat-
egy in the Volta Region was found to be coherent with 
the guidelines in terms of not treating children under 
6  months, is reaching the poorest in coherence with its 
intention of being a “pro-poor” intervention and it is 
more used when there is no health facility close to the 
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house. It is worth noting that a study in Uganda in 2007 
[38] concluded that HBC was less likely to reach the 
poorest and the authors could not explain why. Two other 
studies in Uganda and Zambia found that proximity to a 
health facility is a deterrent against HBC utilization [42, 
43] and another one found that HBC is not cost-effective 
in the context of proximity to a health facility [11]. For 
future planning and considering only the therapeutic 
component of the HBC (which is the one evaluated in 
this paper), implementation of HBC should consider to 
target areas without a health facility (as it was with the 
strategy of the NMCP in the Volta Region).
With regards to CHPS utilization, proximity to a CHPS 
was found to be associated to CHPS utilization in the 
Northern Region (and not in the Volta Region, were car-
ers chose a provider based on different criteria). The per-
centage of carers visiting a CHPS compound was higher 
than the results of the LQAS survey (between 6 and 10 % 
of carers visited a CHPS compound when their child was 
sick). No other comparable studies on CHPS utilization 
were found in the literature to contrast these results.
Carers visiting a CBA in the Volta Region and visiting a 
CHPS in the Northern Region did it more promptly when 
compared with other providers. When diagnosed with 
malaria, children visiting a CBA also received ACT more 
promptly than when visiting any other provider in the 
Volta Region (22.4 versus 3.8 %, p = 0.05). Prompt treat-
ment received from a CBA was reported in other stud-
ies conducted in Rwanda [44], Uganda [38, 45], Ghana 
[26, 27], Nigeria [26], Burkina Faso [27, 46], Tanzania 
[47], Ethiopia [27] and Malawi [27]. Most of these studies 
looked at the performance of HBC at a point in time or in 
before-after cross-sectional studies. Only the two studies 
in Uganda (an RCT and a quasi-experimental study) were 
designed to test for a difference in prompt treatment seek-
ing between HBC and standard treatment and their results 
were similar: 62 versus 37 %, p = 0.0001 [45] and a signifi-
cant difference at post intervention (12.3 %, p = 0.05) [38].
Appropriate treatment
Both HBC and CHPS failed in reaching the target of 
treating 100 % of eligible children with ACT, amoxicillin 
and/or ORS +  zinc. This worrying fact should question 
the local health authorities particularly on the adequacy 
of the drug supply chain. Acknowledging the difficulty of 
interpreting the HBC figures due to the low numbers of 
carers visiting a CBA in the Northern Region, it seems 
that HBC was more used and performed better in the 
Volta Region when compared with the Northern Region 
while CHPS in the Northern Region were more used and 
performed better than in the Volta Region.
More malaria cases were treated with quinine (reserved 
for complicated cases) than with ACT in the CHPS of 
Northern Region. As only between 0 and 11  % of cases 
seen in health facilities in Ghana are complicated cases 
[48, 49] a possible explanation for the frequent use of 
quinine could be stock-outs of drugs The percentage of 
uncomplicated malaria cases treated with ACT in this 
study is lower than that found in other studies [23, 26, 
27]. The source of information (CBA records versus car-
ers’ information) could contribute to the different results. 
It is important to note that both, CBA records and carers’ 
information are not the gold standard for collecting this 
type of information, which is considered to be the direct 
observation of CBA work [14]. CBA registers may suffer 
from inaccurate or incomplete reporting and household 
surveys may suffer from recall bias and misunderstand-
ing. However, the few studies that collected data from 
both sources found similar results [14, 26, 27]. As men-
tioned before, other factors that could explain differences 
in performance are better supervision, better supply 
of drugs with the involvement of the research teams, as 
well as a shorter duration of the research projects when 
compared to program implementation. Another study 
conducted in Burkina Faso [46] with less external super-
vision or anti-malarial supply had similar results to this 
study (54 % of the febrile children received ACT from a 
CBA).
With regards to diarrhoea management, a common 
finding was the low percentage of cases correctly treated 
and children receiving either ORS or zinc, but not both at 
the same time. The LQAS survey in the Northern Region 
also found a low proportion of diarrhoea cases treated 
with ORS and zinc when visiting a CBA or a CHPS, sug-
gesting that it might be due to stock-outs of drugs. CBAs 
are provided with drugs during the monthly community 
welfare clinics conducted by CHPS’ or health centres’ 
nurses. However, this integration of services does not 
seem to cover all drug needs. Results of the 2011 MICS 
and the 2014 DHS also showed a low proportion of diar-
rhoea cases correctly treated (2011 MICS: 32 and 30.1 % 
of diarrhoea cases received ORS and 0 and 0.2 % received 
zinc from an appropriate provider excluding pharmacies 
in the Volta and Northern Regions respectively; 2014 
DHS: 41.3 and 48.7  % of diarrhoea cases received ORS 
and 0 and 5  % received zinc from an appropriate pro-
vider excluding pharmacies in the Volta and Northern 
Regions). The low coverage of ORS and almost negligi-
ble use of zinc to treat diarrhoea cases was also reported 
by Gill et al. [50]. In their paper about bottlenecks, barri-
ers and solutions to the low implementation of effective 
measures to reduce childhood pneumonia and diarrhoea 
deaths in low and middle income countries, they stated 
that the main bottlenecks for diarrhoea appropriate treat-
ment were concentrated in downstream areas related to 
provision of ORS and zinc in the community.
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The study results regarding the appropriate treatment 
of suspected pneumonia cases cannot be compared with 
the 2011 MICS and the 2014 DHS as these surveys did 
not report on this indicator based on the different provid-
ers visited. Another three studies conducted in Africa on 
HBC [43, 51, 52] showed a better performance (between 
63 and 98  % of suspected cases received amoxicillin). 
However, two of them [43, 51] used a different meth-
odology to diagnose suspected pneumonia cases (regis-
tries and direct observation of CBA as opposed to carers’ 
reports) and another one used carers reported symptoms 
but in the context of a cluster randomized trial.
Finally, there is the need to reflect on the fact that some 
cases received amoxicillin, ORS or zinc when visiting a 
CBA in the Volta Region (as the GFATM is only support-
ing ACT). It seems feasible to believe that CBAs still had 
some of these drugs distributed in 2013 in stock, or CBAs 
bought these drugs to be distributed among sick children.
CBA’s referrals and second visit to health providers
This study showed a higher proportion of carers that 
sought care elsewhere after visiting a CBA than the study 
in Dangme West district [23] (where only 3.9  % of the 
carers sought care elsewhere). Since for the HBC strategy 
in the Volta Region CBAs were expected to refer diar-
rhoea and suspected pneumonia cases, one would expect 
a higher proportion of carers seeking care elsewhere in 
the Volta Region. However, 63 and 42 % of carers in the 
Northern and Volta Region sought care elsewhere after 
visiting a CBA because of unavailability of drugs and chil-
dren not getting better. This is coherent with the LQAS 
survey where only 16 % of the CBAs had ACT, ORS, Zinc 
and amoxicillin on the day of the survey in the Northern 
Region. With regards to the HBC in the Volta Region, it 
is important that iCCM coordinators emphasize on the 
importance of referral with a form, as seeking care else-
where can be seen as a failure of the program while refer-
ral can be interpreted as appropriate management of 
cases.
The low coverage of appropriate treatment found 
should make us reflect upon the new “Integrated com-
munity case management guidelines” which will include 
pregnancy and neonatal care, nutrition in under-fives 
and the inclusion of RDT for the diagnosis of malaria. 
Before adding more components to the HBC strategy, 
adherence to protocol through ensuring availability of 
drugs, adequate supervision and continuous replacement 
of CBAs must be ensured.
Users’ satisfaction
Lack of availability and affordability of drugs were the 
main factors for carer dissatisfaction of services in both 
regions. Therefore, emphasis must be given to avoiding 
drug stock outs. Also, a reflexion must be undertaken 
about carers paying CBAs for drugs. Although pay-
ing for CBAs’ drugs can be a strategy to retain CBAs in 
their task, carers valued free drugs as a positive element 
of the HBC strategy. Secondly, it is a contradiction with 
the NHIS which established free treatment for children 
under-five. Thirdly, because this practice is not consid-
ered in the guidelines, which only states “to ensure that 
cost of iCCM would not be a barrier to accessing treat-
ment, drugs should be given to clients at no cost or 
National Health Insurance Scheme (NHIS) may cover all 
drugs”.
Limitations of the study
Response rate was very high for the survey with no refus-
als to participate. The variables described in the study 
represent only the population of sick children during 
the last 2  weeks prior the interview and not the whole 
population.
The study looked at programme implementation 
against guidelines of the national programme. Compari-
son between north and south was descriptive, under-
standing that regions are different from the cultural 
and epidemiological point of view and without directly 
comparing malaria HBC with integrated HBC. Different 
epidemiological burden would not be expected to influ-
ence results, as the target population was children with 
symptoms. However, finding these children when doing 
the data collection was easier in the Northern Region as 
the prevalence of the three diseases was higher. As this is 
a cross-sectional study, no reference to causality can be 
made, only association among variables.
Results are based on responses of carers of children 
under-five. Morbidity data collected is subjective as 
it is based on a mother’s perception of illness and their 
understanding about their children’s disease and the 
treatment given, with no validation of their responses by 
for example comparison with that of the CBAs by looking 
at the CBAs forms or CHPS registries. Therefore, inter-
preting results particularly related to suspected pneumo-
nia must be done with caution as fast breathing, chest in 
drawing or noisy breathing can be perceived differently 
by the carers and the provider and therefore, treated dif-
ferently. The same is the case with diagnostic procedures 
and treatment given and understood. A patient could 
have been given “artesunate-amodiaquine” but referred 
to have received “amodiaquine”. Or the patient might not 
remember the name of the drug, even with the help of 
the drugs pictures that were taken to the field to conduct 
the survey. However, the use of carers’ reports to classify 
malaria, diarrhoea and suspected pneumonia has been 
used in the MICS, DHS and other studies [52]. In addi-
tion, two studies on anti-malarial use and dosage using 
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both sources of data (HBC records and carers’s reports) 
showed similar results [26, 27]. Finally if some children 
were misclassified (for example being attributed with 
one symptom while they do not have it), this is not likely 
to have introduced a differential bias between HBC and 
CHPS.
Some of the results had large confidence intervals even 
though the formula used to calculate the sample size was 
adequate. The clustering of indicators by district was 
larger than expected and therefore a bigger design effect 
could have been more appropriate (Design effect  =  2 
instead of 1.5). As a result, the sample size was small for 
some indicators.
Conclusions
HBC was more used in the Volta Region while CHPS was 
more used in the Northern Region. HBC utilization was 
almost non-existent in the Northern Region. Poorer chil-
dren, children older than 6  months and those living far 
from a health facility were more likely to use HBC in the 
Volta Region. HBC contributed to prompt treatment of 
fevers in the Volta Region.
Appropriate treatment for the three diseases was low 
in the HBC and CHPS areas, in the Volta and Northern 
Regions. Carers were satisfied with the services received. 
Lack of availability and affordability of drugs were the 
factors more reported as cause of dissatisfaction.
More efforts should be made in the provision of drugs, 
ensuring that CBAs are in service and in monitoring the 
CBA and CHPS performance, especially if more com-
ponents are to be included in the HBC strategy. A well-
functioning integration of services might help to improve 
provision of drugs and supervision. Sustainability of HBC 
needs to be addressed. A cost-effectiveness study of the 
HBC compared with CHPS might help to guide decisions 
on future financing and motivation to CBA in Ghana.
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